Article [report]

GlaxoSmithKline Targets Low Cost Vaccine For Malaria

From (verified), January 21, 2010

Health & Nutrition, Community Impact, Mission & Values

GlaxoSmithKline has said that it will aim to keep prices for its planned malaria vaccine low – taking only a five percent profit on manufacturing costs – in order to make it available to poor communities where it is needed. The company has also put into the public domain thousands of potential drugs that might help spark future non–profit research into the disease.

Submitted by brian

Add your vote based on this article ?

This article has issues related to...

Before you vote, please read our Guide to Voting

(Check all that apply)

Discussion ?

Please sign in to post to this discussion

No comments yet.

How this article affects labels?
( based on 8 votes )

person people planet

Please log in and vote to see how other users voted

Companies in this Article
( mouse over to see the nutrition labels )